Optimization of personalized therapy in patients with chronic heart failure


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Six-minute walk tests showed that the incorporation of ethylmethylhydroxypyridine malate (100 mg/day intravenously) into the treatment regimen for chronic heart failure (CHF) allowed a significantly (p=0.04) greater number (33.3%) of patients to have a lower functional class of CHF (17.8% of those receiving the standard treatment regimen).

Full Text

Restricted Access

About the authors

V. Kukes

I.M. Sechenov First Moscow State Medical University (Sechenov University)

E. Shikh

I.M. Sechenov First Moscow State Medical University (Sechenov University)

A. Zhestovskaya

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Email: a.s.zhestovskaia@gmail.com

A. Prokofyev

I.M. Sechenov First Moscow State Medical University (Sechenov University); Research Center for Examination of Medical Products

V. Drozdov

I.M. Sechenov First Moscow State Medical University (Sechenov University)

V. Smirnov

I.M. Sechenov First Moscow State Medical University (Sechenov University); Research Center for Examination of Medical Products

L. Pavlova

I.M. Sechenov First Moscow State Medical University (Sechenov University)

References

  1. ВОЗ. Информационный бюллетень №317. Январь 2015 г.
  2. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC // Eur. Heart J. - 2016; 37 (27): 2129-200. doi: 10.1093/eurheartj/ehw128.
  3. Лукьянова Л.Д. Современные проблемы и перспективы фармакологической коррекции гипоксических состояний. В кн. Фармакотерапия в неврологии и психиатрии / М., 2002; с. 22-34.
  4. Смирнов А.В., Криворучко Б.И. Антигипоксанты в неотложной медицине // Анестезиология и реаниматология. - 1998; 2: 50-5.
  5. Sullivan M., Higginbotham M., Cobb F. Exercise training in patients with chronic heart failure delays ventilatory anaerobic threshold and improves submaximal exercise performance // Circulation. - 1989; 79 (2): 324-9. doi: 10.1161/01.CIR.79.2.324.
  6. Лукьянова Л.Д. Новые подходы к созданию антигипоксантов метаболического действия // Вестн. РАМН. - 1999; 3: 18-25.
  7. Лукьянчук В.Д., Савченкова Л.В. Антигипоксанты: состояние и перспективы // Эксперим. и клин. фармакол. - 1998; 61 (4): 72-9.
  8. Гацура В.В. Фармакологическая коррекция энергетического обмена ишемизированного миокарда / М.: «Антекс», 1993; 254 с.
  9. Кукес В.Г., Прокофьев А.Б., Горошко О.А. и др. Влияние этилметилги-дроксипиридина малата на напряжение кислорода в крови у пациентов с хронической сердечной недостаточностью // Лекарственные средства и рац. фармакотер. - 2013; 3: 18-22.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies